+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Live Attenuated Vaccine"

From
From
From
U.S. Vaccines Market: Opportunity Analysis and Industry Forecast, 2024-2033 - Product Thumbnail Image

U.S. Vaccines Market: Opportunity Analysis and Industry Forecast, 2024-2033

  • Report
  • December 2024
  • 90 Pages
  • United States
From
From
UK Vaccines Market: Opportunity Analysis and Industry Forecast, 2024-2033 - Product Thumbnail Image

UK Vaccines Market: Opportunity Analysis and Industry Forecast, 2024-2033

  • Report
  • November 2024
  • 150 Pages
  • United Kingdom
From
From
From
From
Loading Indicator

Live attenuated vaccines are a type of vaccine that use a weakened form of a virus or bacteria to stimulate an immune response. These vaccines are designed to replicate the natural infection process, allowing the body to develop immunity without the risk of serious illness. Live attenuated vaccines are typically administered orally or nasally, and are often used to protect against diseases such as measles, mumps, rubella, and rotavirus. Live attenuated vaccines are generally considered to be safe and effective, and are often used in combination with other vaccines to provide broader protection. They are also cost-effective, as they require fewer doses than other types of vaccines. Notable companies in the live attenuated vaccine market include Merck & Co., GlaxoSmithKline, Sanofi Pasteur, Pfizer, and Novartis. Show Less Read more